secwatch.observer — SEC 8-K summary
======================================

Issuer:     Coherus Oncology, Inc. (CHRS)
CIK:        0001512762
Form:       8-K
Filed at:   2026-01-23T23:59:59+00:00
Accession:  0001104659-26-006307
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Coherus Oncology files prospectus supplement for $64.9M ATM stock offering
--------------------------------------------------------------------------

- Aggregate offering price of up to $64,880,054 under Sales Agreement with TD Cowen.
- Shares of common stock may be sold from time to time at then-prevailing market prices.
- Legal opinion of Latham & Watkins on share validity filed as Exhibit 5.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1512762/000110465926006307/0001104659-26-006307-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1512762/000110465926006307/tm263459d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-006307

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer